Lunenburg, Canada Clinical Trials

A listing of Lunenburg, Canada clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 6 clinical trials
Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease

This is a Phase 3, randomized, double-blind, placebo-controlled study to explore the effect of oral ozanimod as an induction treatment for subjects with moderately to severely active Crohn's Disease.

ileal disease
corticosteroids
crohn's disease
endoscopy
immunomodulators
Viable Clinical Research
 (9.6 away) Contact site
  • 865 views
  • 09 Mar, 2021
  • +420 other locations
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease

This is a Phase 3, open-label, multicenter extension study to evaluate safety and efficacy of ozanimod in subjects with moderately to severely active Crohn's Disease.

crohn's disease
remission
Viable Clinical Research
 (9.6 away) Contact site
  • 1035 views
  • 22 Feb, 2021
  • +807 other locations
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease

This is a Phase 3, randomized, double-blind, placebo-controlled study to demonstrate the effect of oral ozanimod as maintenance therapy in subjects with moderately to severely active Crohn's Disease.

crohn's disease
remission
abdominal pain
Viable Clinical Research
 (9.6 away) Contact site
  • 858 views
  • 23 Feb, 2021
  • +780 other locations
A Phase 3 Study to Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and Fibrosis

A double-blind placebo controlled randomized Phase 3 study to determine if 80 or 100 mg of MGL-3196 as compared with placebo resolves NASH on liver biopsy and prevents progression to cirrhosis and/or advanced liver disease

cirrhosis
fibroscan
mri-pdff
liver disease
ballooning degeneration
South Shore Medical Arts
 (9.9 away) Contact site
  • 167 views
  • 17 Jul, 2021
  • +229 other locations
Efficacy and Safety of Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With a History of Frequent Exacerbations

Phase 3 study to evaluate the efficacy and safety of a benralizumab in patients with moderate to very severe COPD with a history of frequent COPD exacerbations and elevated peripheral blood eosinophils (300/L). Eligible patients must have a history of 2 moderate and/or severe COPD exacerbations in the previous year …

bronchodilator
antibiotics
eosinophil count
corticosteroids
severe chronic obstructive pulmonary disease
Research Site
 (9.6 away) Contact site
  • 838 views
  • 04 Aug, 2021
  • +426 other locations
Golimumab for Adherence in Rheumatoid Arthritis

The purpose of this study is to determine if non-adherence to Rheumatoid Arthritis (RA) drugs in participants treated with biologic disease modifying anti-rheumatic drugs (DMARDs) is associated with a greater incidence of disease in clinical practice.

antirheumatics
rheumatic diseases
golimumab
DMARD
Fredericton Medical Clinic
 (156.4 away) Contact site
  • 187 views
  • 17 Jul, 2021
  • +37 other locations